Old Web
English
Sign In
Acemap
>
Paper
>
Novel Oral-edaravone Attenuates Diastolic Dysfunction of Diabetic Cardiomyopathy via Activating the Nrf2 Signaling Pathway
Novel Oral-edaravone Attenuates Diastolic Dysfunction of Diabetic Cardiomyopathy via Activating the Nrf2 Signaling Pathway
2021
Ling Wang
Yue-Qin Zeng
Juan-Hua Gu
Rui Song
Peng-Hui Cang
Yong-Xuan Xu
Xiao-Xia Shao
Li Jin Pu
Hai-Yun Luo
Zhou Xinfu
Keywords:
nrf2 signaling
Diabetic cardiomyopathy
Cardiology
Medicine
Internal medicine
Edaravone
Diastole
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]